Based on previous result that enhanced Nrf2 expression could contribute to MAPK and NF-κB pathway inhibition, we investigated here whether Myr could still prevent cardiac hypertrophy after Nrf2 knockdown (Nrf2-KD). Here, NFKB1 is linked to cardiac hypertrophy.